Researchers are developing a genetic test to predict prostate cancer aggressiveness, which could save men with low-risk tumours from unnecessary surgery. Researchers at Queen Mary, University of London in the UK have found that men with high levels of cell-cycle progression genes are more likely to have aggressive prostate cancer tumours. In a study involving 703 men with prostate cancer, researchers found that men with the highest levels of cell-cycle progression genes were three times more likely to have a fatal form of prostate cancer. Among the patients who had surgery to remove their prostate, those who had the highest levels of cell-cycle progression genes were 70 percent more likely to have their cancer return. Lead researcher Jack Cuzick said that since cell-cycle progression genes are expressed at higher levels in actively growing cells, it is possible to measure the growth rate and inherent aggressiveness of the tumour through the new test.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Research


whatsapp--v1